Treatment
This study consists of two different treatment options:
Arm A: 3 cycles carboplatin + paclitaxel maintenance therapy with niraparib
Arm B: 6 cycles carboplatin + paclitaxel maintenance therapy with niraparib
You will be randomly allocated to one of the treatment groups on a 1:1 ratio.
Treatment duration
The treatment can continue until disease progression, unacceptable toxicity or withdrawal of consent.
Contact
To be able to give you the best information and care we do not give medical advice via mail. We kindly ask you to make an appointment via lgog@uzleuven.be.